瑞士HIV队列研究显示老年感染者不适当处方普遍且存在性别差异
该研究回顾性分析瑞士HIV队列中175例≥75岁感染者病历,用Beers标准、STOPP/START标准及利物浦药物相互作用数据库筛查不适当处方。结果显示多药治疗与不适当处方 prevalence 分别为66%和67%,40%处方问题可能有害,女性风险显著高于男性(OR 8.3)。
要点
- ≥75岁HIV感染者中多药治疗和不适当处方均约2/3。
- 40%处方问题可能造成不良后果,主要涉及非HIV药物。
- 女性不适当处方风险显著高于男性(OR 8.3)。
核心结论
- 老年HIV感染者中多药治疗和不适当处方高度普遍,女性风险高于男性。
研究设计与样本
- 瑞士HIV队列研究回顾性病历审查,纳入175例年龄≥75岁感染者。
主要发现
- 中位年龄78岁(IQR 76-81),71%为男性,中位非HIV合并症7种(IQR 5-10)。
- 多药治疗 prevalence 66%,不适当处方 prevalence 67%。
- 40%处方问题可能有害,包括剂量错误26%、无适应证21%、处方遗漏17%、老年人不适用药物18%、有害药物相互作用17%。
- 多因素logistic回归显示多药治疗(OR 2.5,95%CI 1.3-4.7)、肾功能损害(OR 2.7,95%CI 1.4-5.1)、中枢神经系统药物(OR 2.1,95%CI 1.1-3.8)和女性(OR 8.3,95%CI 2.4-28.1)为处方问题风险因素。
关键数值与推荐
- 使用Beers标准、STOPP/START标准及利物浦药物相互作用数据库筛查不适当处方。
临床怎么用
- 对老年HIV感染者应进行药物重整和定期处方审查,尤其关注女性、多药治疗、肾功能损害及中枢神经系统药物使用者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The extent of inappropriate prescribing observed in geriatric medicine has not been thoroughly evaluated in people ageing with HIV. We determined the prevalence of and risk factors for inappropriate prescribing in individuals aged ≥75 years enrolled in the Swiss HIV Cohort Study. METHODS: Retrospective review of medical records was performed to gain more insights into non-HIV comorbidities. Inappropriate prescribing was screened using the Beers criteria, the STOPP/START criteria and the Liverpool drug-drug interactions (DDIs) database. RESULTS: For 175 included individuals, the median age was 78 years (IQR 76-81) and 71% were male. The median number of non-HIV comorbidities was 7 (IQR 5-10). The prevalence of polypharmacy and inappropriate prescribing was 66% and 67%, respectively. Overall, 40% of prescribing issues could have deleterious consequences. Prescribing issues occurred mainly with non-HIV drugs and included: incorrect dosage (26%); lack of indication (21%); prescription omission (drug not prescribed although indicated) (17%); drug not appropriate in elderly individuals (18%) and deleterious DDIs (17%). In the multivariable logistic regression, risk factors for prescribing issues were polypharmacy (OR: 2.5; 95% CI: 1.3-4.7), renal impairment (OR: 2.7; 95% CI: 1.4-5.1), treatment with CNS-active drugs (OR: 2.1; 95% CI: 1.1-3.8) and female sex (OR: 8.3; 95% CI: 2.4-28.1). CONCLUSIONS: Polypharmacy and inappropriate prescribing are highly prevalent in elderly people living with HIV. Women are at higher risk than men, partly explained by sex differences in the occurrence of non-HIV comorbidities and medical care. Medication reconciliation and periodic review of prescriptions by experienced physicians could help reduce polypharmacy and inappropriate prescribing in this vulnerable, growing population.
引用
- Livio F, Deutschmann E, Moffa G, et al. Analysis of inappropriate prescribing in elderly patients of the Swiss HIV Cohort Study reveals gender inequity. J Antimicrob Chemother. 2021. PMID: 33279997. doi:10.1093/jac/dkaa505
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。